Venture Capital Report

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Venture Capital Report"

Transcription

1 Venture Capital Report Europe 1Q 2016

2 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market. Highlights for 1Q 2016 include: European venture capital fundraising amount improved significantly from prior quarter and reached a new high; Venture capital investment into European companies declined from 4Q 2015; The number of mergers and acquisitions (M&As) experienced an increase from the last quarter, while the total M&A raised amount decreased significantly; The number of initial public offerings (IPOs) and total amount raised dropped dramatically form 4Q

3 EUROPEAN VENTURE CAPITAL FUNDRAISING ROCKETS IN 1Q 2016 FUNDRAISING 25 European venture capital funds reached a new high of 2.85 billion during 1Q Compared with 4Q 2015, total capital raised more than doubled, and the number of fund closings climbed 19%. Compared with the same period last year, euros raised improved by 169%, and the number of fund closing increased 14%. Index Ventures VIII LP was the largest fund of this quarter, which raised million, accounting for 18% of the total amount raised in 1Q European VC Fundraising Based on multiple closings ( ) Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Amount Raised ( B) Number of Funds

4 LARGEST EUROPEAN VC FUNDS RAISED IN 1Q 2016 FUNDRAISING Firm Name Fund Name Amount ( M) Location Offering Status Fund Type Fund Category Closing Type Index Ventures Index Ventures VIII LP Geneva, Switzerland Closed Early-stage venture capital Venture Capital Final Rocket Internet AG Rocket Internet Capital Partners Fund Berlin, Germany Open Late-stage venture capital Venture Capital First Endeavour Vision SA Endeavour Medtech Growth LP Geneva, Switzerland Closed Multi-stage venture capital Venture Capital Final Medicxi Ventures Medicxi Ventures I London, United Kingdom Closed Early-stage venture capital Venture Capital Final Creandum Creandum IV Stockholm, Sweden Closed Early-stage venture capital Venture Capital Final 4

5 INVESTMENT INTO EUROPEAN VENTURE-BACKED COMPANIES DECLINED IN 1Q 2016 FINANCING European companies raised 2.4 billion through 411 deals during 1Q 2016, a 29% decline in the amount raised from the prior quarter as well as a 12% drop in the number of deals. Compared with the same period last year, both investment amount and the number of deals decreased, 17% and 2% respectively. Healthcare was the strongest sector of the quarter in terms of attracting investment Equity Financings into Europe-based, VC-backed Companies ( ) Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Amount Raised ( B) Number of Deals

6 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY ROUND CLASS ( ) NUMBER OF DEALS FINANCING Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Seed First Second Later Restart

7 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY ROUND CLASS ( ) AMOUNT RAISED ( M) FINANCING 2,500 2,000 1,500 1, Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Seed First Second Later , ,752 2,179 1,873 1, Restart

8 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES ( ) MEDIAN EQUITY DEAL SIZE ( M) FINANCING Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Median Equity Deal Size ( M)

9 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY INDUSTRY GROUP (1Q 2016) FINANCING Healthcare received the largest allocation of investment during 1Q 2016, raising million through 62 deals. The sector attracted a 31% of the total amount invested and a 15% of all deals completed for the quarter. Business and Financial Services ranked the second highest proportion of investment. The sector garnered million across 116 deals, an increase of 5% in deal number and a less than 1% drop in amount invested from 4Q Consumer Services represented the third, receiving million across 97 deals. The sector s investment figure represents 20% of the total equity financing into European VC-backed companies for 1Q Q'16 Industry Breakdown By Number of Deals 1Q 16 Industry Breakdown By Amount Raised 1% 1% 25% 15% 17% 1% 24% 29% 28% 4% Business and Financial Services Consumer Goods Consumer Services Energy & Utilities Healthcare Industrial Goods & Materials Information Technology Business and Financial Services Consumer Goods Consumer Services Energy & Utilities 1% Healthcare 31% 1% 20% Industrial Goods & Materials Information Technology 9

10 TOP 5 DEALS INTO EUROPEAN VC-BACKED COMPANIES (1Q 2016) FINANCING Co. Name Location Industry Code Industry Segment Industry Group Brief Description Close Date Round Type Raised ( M) Round Investors (* denotes lead) Mission Therapeutics Ltd. Cambridge, United Kingdom Biotechnology Therapeutics Biopharmaceuticals Healthcare Developer of drugs designed to improve the management of lifethreatening diseases, particularly cancer. 2/2/2016 3rd Imperial Innovations Group PLC*, Pfizer Venture Investments, Roche Venture Fund, Sofinnova Partners, SR One Ltd., Woodford Investment Management LLP* Autolus Ltd. London, United Kingdom Biotechnology Therapeutics Biopharmaceuticals Healthcare Provider of biopharmaceutical solutions. 3/3/2016 Second Round Perceptive Bioscience Investments Ltd., Woodford Investment Management LLP Student.com (UK) Ltd. London, United Kingdom Hotels / Gambling Travel and Leisure Consumer Services Provider of an accommodation marketplace for students studying abroad. 10/2/2016 First Round Expa Capital, Horizons Ventures Ltd., Individual Investors, Vy Capital Management Co. Ltd.* Blippar.com Ltd. London, United Kingdom Recreational / Home Software Software Information Technology Provider of a mobile image recognition and augmented reality platform. 2/3/2016 Second Round Khazanah Nasional Berhad* Aprea AB Solna, Stockholm Biotechnology Therapeutics Biopharmaceuticals Healthcare Developer of drugs for the treatment of cancer. 9/3/2016 Later 46 5AM Venture Management LLC*, HealthCap Venture Capital*, Sectoral Asset Management Inc., Versant Venture Management LLC* 10

11 MOST ACTIVE INVESTORS FOR EUROPE-BASED, VC-BACKED COMPANIES (1Q 2016) BY DEALS COMPLETED FINANCING Bpifrance Investment High-Tech German Startups Gruenderfonds Group Berlin GmbH Management GmbH & Co. KGaA Jenson Funding Partners LLP Bayern Kapital GmbH Idinvest Partners HV Holtzbrinck Ventures Adviser GmbH Index Ventures 11

12 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES BY COUNTRY (1Q 2016) FINANCING Number of Deals in 1Q 2016 by Country (Top 4) 29% 27% United Kingdom France The United Kingdom remained as the most favoured destination for equity financing during 1Q 2016, receiving 974 million across 111 deals. The country took 40% of all equity financing from 1Q Germany ranked second. It reached a total 463 million through 75 deals, representing a 19% share of European financing. A 33% decrease in capital invested and 13% drop of the number of deals from last quarter. France occupied third position raising 354 million, 15% of the total for the quarter. Sweden placed fourth based on raising 99 million during 1Q Amount Raised in 1Q 2016 by Country (Top 4) 5% 18% 22% 4% 23% 21% 40% Germany Netherlands Rest of Europe United Kingdom Germany France 15% 19% Sweden 19% Rest of Europe 12

13 EUROPE 1Q 2016 VENTURE EXIT ACTIVITY LIQUIDITY Exit Opportunities for European VC backed Companies ( ) 50 venture-backed M&As took place in Europe during 1Q 2016, a 28% increase from 4Q The number is 6% lower than that of 1Q However, total amount raised through European VCbacked M&As in 1Q 2016 is only 3.7 billion. A 45% drop from the prior quarter and 16% lower than the same period last year. 5 venture-backed IPOs took place during 1Q 2016, a 64% and 58% decrease from 4Q 2015 and 1Q 2015 respectively. 1Q'16 4Q'15 3Q'15 2Q'15 1Q'15 4Q'14 3Q'14 2Q'14 1Q'14 4Q'13 3Q'13 2Q'13 1Q' Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 IPOs M&As

14 TOP 3 M&As IN EUROPE (1Q 2016) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Amount Paid ( M) Acquirer Acano Ltd. Uxbridge, United Kingdom Provider of collaboration infrastructure and conferencing software. Communications Software Software Information Technology 29/1/2016 Acquisition Cisco Systems TouchType Ltd. London, United Kingdom Provider of predictive text entry software. Communications Software Software Information Technology 2/2/2016 Acquisition Microsoft Corp. CityFibre Infrastructure Holdings Plc Provider of dark fibre networks in London, towns and cities outside London United Kingdom on a shared infrastructure basis. Internet Service Providers Communications and Networking Information Technology 14/1/2016 Acquisition KCOM Group Plc 14

15 EUROPEAN VC-BACKED IPOs ( ) LIQUIDITY Both the number of deals and amount raised via IPO during 1Q 2016 dropped significantly from the prior quarter. 5 venture-backed companies went public during 1Q 2016, 64% decrease from the last quarter. IPOs raised 110 million during 1Q 2016, a decline of 82% from the 608 million raised in 4Q The largest European VC-backed IPO of 1Q 2016 was Shield Therapeutics Ltd. The company raised million for its offering on AIM. 2, , , , Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Raised ( M) through IPO , Number of IPOs

16 TOP 3 IPOs IN EUROPE (1Q 2016) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Raised through IPO ( M) Exchange/ Symbol Shield Therapeutics Ltd. United Kingdom Developer of late-state, secondary care-focused pharmaceuticals. Biotechnology Therapeutics Biopharmaceuticals Healthcare 12/2/ AIM: STX Biotechnology Research & Information Network AG Germany Provider of drugs, bioactive natural compounds, and proprietary enzymes for businesses in the chemical, pharmaceutical, food, and cosmetics industries. Pharmaceuticals Biopharmaceuticals Healthcare 9/2/ FWB: BNN Blue Prism Group PLC United Kingdom Provider of Robotic Process Automation (RPA) software. Business Applications Software Software Information Technology 18/3/ LSE: PRSM 16

17 ABOUT US Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service provider find deal and partnership opportunities, perform comprehensive due diligence and examine trends in venture capital investment, fund-raising and liquidity. It provides accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry and stage of development throughout the world. The investment figures included in this release are based on aggregate findings of Dow Jones proprietary research and are contained in VentureSource. This data was collected through survey of professional firms, interviews with company executives, and from secondary sources. These venture capital statistics cover equity investments into early stage, innovative companies and do not include companies receiving funding solely from corporate, individual, and/or government investors. Figures contained throughout the report current at time of editorial but are subject to change without notice. No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice. 17

18 ABOUT DOW JONES Dow Jones is a global provider of news and business information, delivering content to consumers and organizations around the world across multiple formats, including print, digital, mobile and live events. Dow Jones has produced unrivaled quality content for more than 130 years and today has one of the world s largest newsgathering operations globally. It produces leading publications and products including the flagship Wall Street Journal, America s largest newspaper by paid circulation; Factiva, Barron s, MarketWatch, Financial News, DJX, Dow Jones Risk & Compliance, Dow Jones Newswires and Dow Jones VentureSource. Dow Jones is a division of News Corp [NASDAQ: NWS, NWSA; ASX: NWS, NWSLV]. MEDIA CONTACT: Sophie Bent +44 (0)

Venture Capital Report

Venture Capital Report Europe 1Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs

More information

Venture Capital Report

Venture Capital Report China 2Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

Venture Capital Report

Venture Capital Report U.S. 2Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

Venture Capital Report

Venture Capital Report U.S. 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

Life Sciences Financing Summary Europe December 2014

Life Sciences Financing Summary Europe December 2014 Europe December 2014 In stark contrast to their summer inactivity, private Biotech European companies (Therapeutics & Diagnostics) raised the highest equity financing amount of the year in September with

More information

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo 1 Overview 1. Venture Valuation 2. Trends in the EU Biotech & Pharma 3. Overview European Biotechs / Clusters 2 Valuation Valuation Mission Independent

More information

Site Selection for Life Sciences Companies

Site Selection for Life Sciences Companies Site Selection for Life Sciences Companies Dr. Patrik Frei January 2015 San Francisco 0 European Life Sciences Clusters European Life Sciences Clusters Countries included: Austria, Belgium, Denmark, Finland,

More information

Backing the companies of tomorrow. //////////////////////////////////////////// Creandum Nordic Technology Exit Analysis

Backing the companies of tomorrow. //////////////////////////////////////////// Creandum Nordic Technology Exit Analysis Backing the companies of tomorrow //////////////////////////////////////////// Creandum Nordic Technology Exit Analysis 1 Creandum exit database Database with 300+ private technology company exits 20+

More information

Q2.15: Cleantech and Renewable Energy Investment Review

Q2.15: Cleantech and Renewable Energy Investment Review Q2.15: Cleantech and Renewable Energy Investment Review 02 Welcome to Taylor Wessing s analysis of clean energy investment activity in Europe in the second quarter of 2015 (Q2.15). Total investment in

More information

Thomson Reuters Venture Capital Index Methodology. Contents. Introduction. Version 1.0

Thomson Reuters Venture Capital Index Methodology. Contents. Introduction. Version 1.0 1 Thomson Reuters Venture Capital Index Methodology Version 1.0 Contents Introduction... 2 Weighting Methodology... 4 Venture Capital Sector Indices... 4 Weight Computation... 5 Index Computation... 5

More information

Biotech funding surges

Biotech funding surges www.pwc.com Biotech funding surges Biotechnology investments in the fourth quarter of 2014 reached the highest level recorded since the MoneyTree TM data series was launched in 1995, breaking a record

More information

Biotech hits record first quarter high

Biotech hits record first quarter high www.pwc.com Biotech hits record first quarter high Biotechnology increased by high double digits compared to first quarter of last year; Medical devices declined over the same period 2 PwC US venture capital

More information

Choosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010

Choosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010 Choosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010 Columbia University Entrepreneurial Program April 2010 www.morganlewis.com Outline I. Overview II. Choosing

More information

Guide to the European Life Science Venture Capital Market

Guide to the European Life Science Venture Capital Market BioSeeker Group AB Highlight Report Guide to the European Life Science Venture Capital Market March 2003 BioSeeker Group www.bioseeker.com Executive Summary The risks in the life science business heightened

More information

State of the Life Sciences Mergers and Acquisitions Market

State of the Life Sciences Mergers and Acquisitions Market State of the Life Sciences Mergers and Acquisitions Market Brian Miller, Managing Partner and Co-Founder, Linden Partners Rich Fante, RF Consulting LLC, Formerly with AstraZeneca Americas Mark Nicholson,

More information

Contents. China Early-stage Investment Report China Early-stage Investments Report 2012

Contents. China Early-stage Investment Report China Early-stage Investments Report 2012 China Early-stage Investments Report 2012 Contents China Early-stage Investment Report 2012 1 1.1 Early-stage Investments in Foreign Countries 1 1.1.1 Early State Investments in the US 6 1.1.2 Development

More information

Global ex U.S. Developed and Emerging Markets Private Equity and Venture Capital Indices Returns (%) in U.S. Dollars Periods ending June 30, 2013

Global ex U.S. Developed and Emerging Markets Private Equity and Venture Capital Indices Returns (%) in U.S. Dollars Periods ending June 30, 2013 Overview Cambridge Associates LLC Global ex U.S. Developed and Emerging Markets Private Equity and Venture Capital Benchmark Commentary Quarter Ending June 30, 2013 During the second quarter, in U.S. dollar

More information

Media for Equity: the newest VC concept from Europe. Elena Bocharova for Berliner Börsenkreis 30 June, 2015

Media for Equity: the newest VC concept from Europe. Elena Bocharova for Berliner Börsenkreis 30 June, 2015 Media for Equity: the newest VC concept from Europe Elena Bocharova for Berliner Börsenkreis 30 June, 2015 Outline: get excited How do you finance a company? A brief overview Media for Equity: what do

More information

Venture-backed ipo exit activity keeps momentum with best full year for new listings since 2000

Venture-backed ipo exit activity keeps momentum with best full year for new listings since 2000 CONTACTS Ben Veghte NVCA 1.202.864.5923 bveghte@nvca.org Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com Venture-backed ipo exit activity keeps momentum with best full year

More information

ALTERNATIVE INVESTMENTS

ALTERNATIVE INVESTMENTS ALTERNATIVE INVESTMENTS Trends in the market for investments in real estate Grand Hôtel Stockholm 27 April 2016 Stephen Ryan Research Manager 2 INREV European Association for Investors in Non-Listed Real

More information

Europe s fastest growing highimpact

Europe s fastest growing highimpact The Tech Tour Growth 50 Europe s fastest growing highimpact private companies in conjunction with: Contents TT Growth 50 Companies 3-4 Key Figures 5-6 Why the Tech Tour Growth 50 7 Sector & Country Analysis

More information

An Overview of Private Equity

An Overview of Private Equity An Overview of Private Equity September 29, 2014 Private Equity Panel Moderator Les Alexander, Partner, Jefferson Capital Partners Panelists Mark Jones, Partner, River Associates Investments Gretchen Perkins,

More information

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements November 2015 Presented by: Stephen Thau 2 BIOTECH IPOS ARE HOT! The Biggest Biotech

More information

US PE/VC Benchmark Commentary Quarter and Year Ending December 31, 2013

US PE/VC Benchmark Commentary Quarter and Year Ending December 31, 2013 US PE/VC Benchmark Commentary Quarter and Year Ending December 31, 2013 In 2013, US private equity and venture capital turned in their best annual performance since 2006 and 1999, respectively. Strong

More information

{ { Women Wheel. at the. Do Female Executives Drive Start-up Success?

{ { Women Wheel. at the. Do Female Executives Drive Start-up Success? { { Women Wheel at the Do Female Executives Drive Start-up Success? contents Executive Summary 3 1 1.1 1.2 1.3 1.4 1.5 Methodology 5 VentureSource Database 5 Executive Information 5 Success 5 Industry

More information

2011 Seed Financing Survey. Internet/Digital Media and Software Industries

2011 Seed Financing Survey. Internet/Digital Media and Software Industries 2011 Seed Financing Survey Internet/Digital Media and Software Industries Background Last year we published our first Seed Financing Survey in recognition of the growing importance of seed financing to

More information

European private equity investment over 40bn in 2014, exits hit record levels, new EVCA data shows

European private equity investment over 40bn in 2014, exits hit record levels, new EVCA data shows European private equity investment over 40bn in 2014, exits hit record levels, new EVCA data shows Brussels 12 May 2015 European private equity investment rises 14% to 41.5bn in 2014 Over 5,500 European

More information

Québec s Venture Capital Market in 2014. Réseau Capital

Québec s Venture Capital Market in 2014. Réseau Capital Québec s Venture Capital Market in 2014 A REPORT PREPARED FOR Réseau Capital FEBRUARY 2015 2015 by Thomson Reuters (Canada); All Rights Reserved All data used for this report derive from the proprietary

More information

Alain Schmitt Directorate General for Enterprise October 14 th, 2014

Alain Schmitt Directorate General for Enterprise October 14 th, 2014 Alain Schmitt Directorate General for Enterprise October 14 th, 2014 I. Facts and figures about innovation in France II. Startup financing III. Entrepreneurship culture and ecosystems Worldwide ranking

More information

Can patent data predict the success of start- ups?

Can patent data predict the success of start- ups? Can patent data predict the success of start- ups? June 2014 This document is the final report of a study commissioned by France Brevets. It has been prepared by Justus Baron, Maria Fayos Herrera, Yann

More information

How does a venture capitalist appraise investment opportunities?

How does a venture capitalist appraise investment opportunities? 1 How does a venture capitalist appraise investment opportunities? Michael Queen - Finance Director, 3i Group plc A presentation to: 23 Pensions Convention 2 June 23 A How presentation does a venture to:

More information

Searching for returns: real estate investors take profits

Searching for returns: real estate investors take profits Hamburg, 14 September 2015 Investor survey: Searching for returns: real estate investors take profits - International pressure to invest opens up selling opportunities - Trend towards higher risk and cross-border

More information

Scandinavian Life Science Funding Report

Scandinavian Life Science Funding Report Scandinavian Life Science Funding Report 2014 2016 Introduction Scandinavian Life Science Funding Report 2014 2016 covers the investment landscape and financing activities in the Life Science sector in

More information

Quarterly Technology M&A Review

Quarterly Technology M&A Review Quarterly Technology M&A Review Q4 01 Technology M&A deal value increased considerably in Q4 01, while deal count dipped to the lowest level since Q4 010. Normalized to remove the impact of Softbank s

More information

The European Perspective

The European Perspective Back on Track Back on Track The European Perspective E UROPEAN INTRODUCTION Back on Track Europe s biotech industry is decisively back on track. After years of consolidation and relatively stagnant results,

More information

Introduction to VC and MAVCAP August 2013

Introduction to VC and MAVCAP August 2013 Introduction to VC and MAVCAP August 2013 www.mavcap.com 1 AGENDA PART I: Brief Introduction to Venture Capital (VC) i. The Funding Spectrum ii. What is VC iii. How VC Works PART II: Brief Introduction

More information

the investment process for the private equity funds and the entrepreneurs

the investment process for the private equity funds and the entrepreneurs This course examines the role of private equity financing, as a type of financing, for the entrepreneurs and the critical issues that the two parties involved in the transaction will face during the investment

More information

Venture Capital and the European Biotechnology Industry

Venture Capital and the European Biotechnology Industry Venture Capital and the European Biotechnology Industry Also by William Bains Biotechnology from A to Z Venture Capital and the European Biotechnology Industry William Bains William Bains 2009 Softcover

More information

Member Finra/SIPC Seed Equity Ventures

Member Finra/SIPC Seed Equity Ventures Member Finra/SIPC 1 Disclaimer Important Information This presentation has been prepared solely for informational purposes. These materials are not an offer to sell nor a solicitation of any offer to purchase

More information

The Venture Capital Rebound How to Generate Outsized Returns 2009-2019

The Venture Capital Rebound How to Generate Outsized Returns 2009-2019 White Paper The Venture Capital Rebound How to Generate Outsized Returns 2009-2019 Roland Reynolds, Principal roland@industryventures.com Ken Wallace, Vice President ken@industryventures.com September

More information

New Zealand Venture Investment Fund INVESTMENT REPORT JANUARY 2016

New Zealand Venture Investment Fund INVESTMENT REPORT JANUARY 2016 New Zealand Venture Investment Fund INVESTMENT REPORT JANUARY 2016 FOR THE YEAR TO 30 JUNE 2015 INTRODUCTION The New Zealand Venture Investment Fund has partnered with 10 venture capital funds and 15 angel

More information

VENTURE CAPITAL 101 I. WHAT IS VENTURE CAPITAL?

VENTURE CAPITAL 101 I. WHAT IS VENTURE CAPITAL? VENTURE CAPITAL 101 I. WHAT IS VENTURE CAPITAL? Venture capital is money provided by an outside investor to finance a new, growing, or troubled business. The venture capitalist provides the funding knowing

More information

Pharma-Biotech Company Valuation - an Introduction Dr. Patrik Frei May 2015 Palermo, Fit for Health 2.0

Pharma-Biotech Company Valuation - an Introduction Dr. Patrik Frei May 2015 Palermo, Fit for Health 2.0 Pharma-Biotech Company Valuation - an Introduction Dr. Patrik Frei May 2015 Palermo, Fit for Health 2.0 Overview Company Valuation Break Product Valuation OVERVIEW rnpv PRODUCT VALUATION COMPANY VALUATION

More information

Q1 14 Global IPO update. January March 2014

Q1 14 Global IPO update. January March 2014 Q1 14 Global IPO update January March 214 Table of contents Section Content Slides 1 214 January March* highlights 4 7 2 Global IPO activity trends Global analysis Regional analysis Industry analysis Stock

More information

Private Tender Offer Best Practices

Private Tender Offer Best Practices Private Tender Offer Best Practices How to Deliver Controlled Liquidity as a Private Company SecondMarket, Inc. 636 Avenue of the Americas New York, NY 10009 212-825-1619 sales@secondmarket.com Introduction:

More information

$15.3 Billion in Venture Capital Deployed to Startup Ecosystem in Second Quarter, According to the MoneyTree Report

$15.3 Billion in Venture Capital Deployed to Startup Ecosystem in Second Quarter, According to the MoneyTree Report Contacts: Tanja Sullivan, PwC US, 646-471-6959, tanja.sullivan@pwc.com Ben Veghte, NVCA, 202-864-5923, bveghte@nvca.org $15.3 Billion in Venture Capital Deployed to Startup Ecosystem in Second Quarter,

More information

Overview. carried interest. Copyright 2014 by Cambridge Associates LLC. All rights reserved.

Overview. carried interest. Copyright 2014 by Cambridge Associates LLC. All rights reserved. Overview Cambridge Associates LLC Global ex U.S. Developed and Emerging Markets Private Equity and Venture Capital Benchmark Commentary Quarter Ending September 30, 2013 During the third quarter, in U.S.

More information

US PE / VC Benchmark Commentary Quarter Ending September 30, 2015

US PE / VC Benchmark Commentary Quarter Ending September 30, 2015 US PE / VC Benchmark Commentary Quarter Ending September 30, 2015 Overview While US private equity and venture capital struggled during third quarter 2015, they both outperformed the S&P 500, the Russell

More information

Introduction to European Investment Fund Supporting Technology driven SMEs through early-stage equity investment. Tbilisi, Georgia, September 2016

Introduction to European Investment Fund Supporting Technology driven SMEs through early-stage equity investment. Tbilisi, Georgia, September 2016 Introduction to European Investment Fund Supporting Technology driven SMEs through early-stage equity investment Tbilisi, Georgia, September 2016 1 What is the EIF? We provide risk financing to stimulate

More information

ATEL Growth Capital Fund 8, LLC. Financing Tomorrow s Technologies... Today

ATEL Growth Capital Fund 8, LLC. Financing Tomorrow s Technologies... Today ATEL Growth Capital Fund 8, LLC Financing Tomorrow s Technologies... Today RISK FACTORS Investors are encouraged to carefully read the Prospectus for ATEL Growth Capital Fund 8, LLC which has been provided

More information

Europe Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast

Europe Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast Report Information More information from: https://www.wiseguyreports.com/reports/592444 Europe Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast Report / Search Code: WGR592444

More information

www.pwc.com IPO Watch Europe Survey Q2 2013

www.pwc.com IPO Watch Europe Survey Q2 2013 www.pwc.com IPO Watch Europe Survey Q2 2013 Contents Quarterly European IPO activity by value and volume 3 Market volatility index and stock market performance 4 IPO offering value 5 IPO volume 6 Top ten

More information

Public funding policies: which options for small innovative companies in 2009. Biotech SMEs in the EU: how to improve access to finance

Public funding policies: which options for small innovative companies in 2009. Biotech SMEs in the EU: how to improve access to finance Public funding policies: which options for small innovative companies in 2009 Biotech SMEs in the EU: how to improve access to finance Dirk Carrez Director, EuropaBio EuroBio - 25 September 2009 (Lille)

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Biotechnology and Venture Capital in Switzerland and Europe

Biotechnology and Venture Capital in Switzerland and Europe Biotechnology and Venture Capital in Switzerland and Europe Venture Valuation VV AG Badenerstr. 587 8048 Zürich Switzerland Phone +41 (1) 405 86 60 Fax + 41 (1) 405 86 61 info@venturevaluation.ch Agenda

More information

Why Venture Capital Does Not Scale

Why Venture Capital Does Not Scale Frost Bank Tower 41 Congress Ave., Suite 295 Austin, TX 7871 (512)721-12 www.santeventures.com Why Venture Capital Does Not Scale Kevin M. Lalande, Managing Director March 15, 211 ASantéVenturesWhitePaperv1.

More information

Somerset Capital 3 rd Annual Family Office Survey 2013. Somerset Capital 3 rd Annual Family Office Survey 2013 Page - 1 -

Somerset Capital 3 rd Annual Family Office Survey 2013. Somerset Capital 3 rd Annual Family Office Survey 2013 Page - 1 - Somerset Capital 3 rd Annual Family Office Survey 2013 Somerset Capital 3 rd Annual Family Office Survey 2013 Page - 1 - SUMMARY In January 2013 Somerset Capital conducted its 3 rd annual survey of the

More information

Press Release 1 st October 2014

Press Release 1 st October 2014 Press Release 1 st October 214 August Sees Largest Equity-Backed Buyout Deal and Exit in the Whole of 214 Year-to-Date The largest deal and exit of the year so far contributed to a small increase in aggregate

More information

Q1.14: Cleantech and Renewable Energy Investment Review

Q1.14: Cleantech and Renewable Energy Investment Review Q1.14: Cleantech and Renewable Energy Investment Review 02 Welcome to Taylor Wessing s analysis of clean energy investment activity in the first quarter of 2014. The year has started on a positive note,

More information

A guide to London Stock Exchange trading services for equity securities

A guide to London Stock Exchange trading services for equity securities A guide to London Stock Exchange trading services for equity securities Contents Background 01 Trading services for equity securities 03 SETS 04 SETSqx 06 SEAQ 08 Criteria and process for allocating securities

More information

Trends in Healthcare Investments and Exits 2014

Trends in Healthcare Investments and Exits 2014 Trends in Healthcare Investments and Exits 214 WRITTEN BY Jonathan Norris Managing Director Silicon Valley Bank t 65 926 126 jnorris@svb.com HEALTHCARE INVESTMENTS STABILIZE AS IPOS SURGE The story of

More information

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge

More information

Private Equity: A Practitioner s Perspective. Edward J. Mathias

Private Equity: A Practitioner s Perspective. Edward J. Mathias Private Equity: A Practitioner s Perspective Edward J. Mathias Private Equity A Practitioner s Perspective The Carlyle Group Overview The Fundamental Case Investor Activity Private Equity Investment Criteria

More information

ACA Member Landscape 2009 Different Than 2008 (And Not)

ACA Member Landscape 2009 Different Than 2008 (And Not) ACA Member Landscape 2009 Different Than 2008 (And Not) April 16, 2009 Summary of ACA Membership April, 2009 Full Members 146 Provisional Members 16 Accredited Investors in 7,062 States & Provinces 49

More information

PRIVATE EQUITY FUNDS IN NORWAY ACTIVITY REPORT 2014

PRIVATE EQUITY FUNDS IN NORWAY ACTIVITY REPORT 2014 NORWEGIAN VENTURE CAPITAL & PRIVATE EQUITY ASSOCIATION (NVCA) PRIVATE EQUITY FUNDS IN NORWAY ACTIVITY REPORT 204 (SEED VENTURE BUY OUT) 2 ABOUT THE ACTIVITY REPORT 204 The Activity Report 204 is developed

More information

SLM Solutions a leader in metal based 3D printing. Investors presentation on the 9M Figures 2014

SLM Solutions a leader in metal based 3D printing. Investors presentation on the 9M Figures 2014 SLM Solutions a leader in metal based 3D printing Investors presentation on the 9M Figures 2014 Direct part manufacturing: metal based 3D printing is for industrial applications 2. 1 Clear growth strategy

More information

[German Hotel Market 2014]

[German Hotel Market 2014] A further record year In 2014 overnight statistics in Germany rose by 3 % to an interim high of approx. 424 m. While overnights in 2013 had primarily been accounted for by international visitors, in 2014

More information

THE ENTREPRENEURS REPORT Private Company Financing Trends

THE ENTREPRENEURS REPORT Private Company Financing Trends THE ENTREPRENEURS REPORT Private Company Financing Trends From the WSGR Database: Financing Trends for Q2 2015 and Rounds by Year - Equity Financings As we reported in Q1 2015, venture money is continuing

More information

Foreign Direct Investment

Foreign Direct Investment Germany Reports Record High of New Investment Projects Germany is a very attractive location for foreign investors. Germany Trade & Invest (GTAI) and the economic development agencies of the German Federal

More information

Canada s Venture Capital Puzzle

Canada s Venture Capital Puzzle An Impact Brief September 2016 Canada s Venture Capital Puzzle Do we have enough funding to compete internationally? Contents Is Canada Lacking Venture Capital Funding? 3 Seed Stage Funding 5 Growth Stage

More information

Private Markets Trends

Private Markets Trends CALLAN INVESTMENTS INSTITUTE Private Markets Trends IN THIS ISSUE pg. 1 Private Equity Fundraising Private Equity Market Environment pg. 3 Regulation Trends Private Equity Returns Spring 2014 Private Equity

More information

Sprott Focused Global Balanced Class Sprott Corporate Class Inc.

Sprott Focused Global Balanced Class Sprott Corporate Class Inc. Sprott Focused Global Balanced Class Sprott Corporate Class Inc. ANNUAL MANAGEMENT REPORT OF FUND PERFORMANCE DECEMBER 31 2015 The annual management report of fund performance is an analysis and explanation

More information

Healthcare IT Funding and M&A

Healthcare IT Funding and M&A Q2 2015 Healthcare IT Funding and M&A Executive Summary Executive Summary Healthcare IT Funding and M&A 2015 Second Quarter Report Funding and merger & acquisition activity for the Healthcare IT / Digital

More information

Nordic Venture Capital:

Nordic Venture Capital: Menon Publication Nordic Venture Capital: Cross Border Investments MENON-PUBLICATION NO. 20 /2010 Gjermund Grimsby, Leo A. Grünfeld and Anne Espelien www.menon.no PO. Box 5250 Majorstuen N0303 Oslo Tel:

More information

NEWS CORPORATION REPORTS FIRST QUARTER RESULTS FOR FISCAL 2016

NEWS CORPORATION REPORTS FIRST QUARTER RESULTS FOR FISCAL 2016 NEWS CORPORATION REPORTS FIRST QUARTER RESULTS FOR FISCAL 2016 FISCAL 2016 FIRST QUARTER KEY FINANCIAL HIGHLIGHTS Revenues of $2.01 billion compared to $2.11 billion in the prior year Reported Total Segment

More information

Assessing Fund Performance:

Assessing Fund Performance: Assessing Fund Performance: Using Benchmarks in Venture Capital Venture Capital Update written by: Bronwyn Dylla Bailey Research Director 650.855.3021 bbailey@svb.com Aaron Gershenberg Managing Partner

More information

Investing in Rapid Growth, High Potential Companies

Investing in Rapid Growth, High Potential Companies Growth Capital: Investing in Rapid Growth, High Potential Companies Venture Capital Update written by: John Dominguez Partner 650.855.3048 jdominguez@svbcapital.com Bronwyn Dylla Bailey Research Director

More information

TECH TRENDS & INSIGHTS

TECH TRENDS & INSIGHTS TECH TRENDS & INSIGHTS Analysis of the Tech Sector in New York Q4 214 ANALYSIS MARCH 215 Highlights P.1 NY VC funding up 53% in 214 P.1 NY takes 15% of Internet VC funding nationally P.3 Late stage deal

More information

EMBARGOED UNTIL 12:01 AM EST, TUESDAY, JANUARY 24. VENTURE CAPITAL INVESTING STEADY AT $21.7 BILLION IN 2005 HOLDING ON TO 2004 s GAIN

EMBARGOED UNTIL 12:01 AM EST, TUESDAY, JANUARY 24. VENTURE CAPITAL INVESTING STEADY AT $21.7 BILLION IN 2005 HOLDING ON TO 2004 s GAIN Contacts: Emily Mendell, National Venture Capital Association, 610-565-3904, emendell@nvca.org Lisa Peterson, Porter Novelli for PricewaterhouseCoopers, 512-241-2233, lisa.peterson@porternovelli.com Mary

More information

INDUSTRY OVERVIEW HISTORY OF THE HONG KONG STOCK MARKET. Development of the stock market

INDUSTRY OVERVIEW HISTORY OF THE HONG KONG STOCK MARKET. Development of the stock market This section contains certain information which has been directly or indirectly derived, in part, from various governmental, official, publicly available documents, the internet or other sources, which

More information

New reality prompts U.S. startups to focus on fundamentals

New reality prompts U.S. startups to focus on fundamentals Innovation Economy Outlook 2016 U.S. STARTUP OUTLOOK 2016 New reality prompts U.S. startups to focus on fundamentals Innovation Economy Outlook 2016 1 Letter from SVB s CEO We are pleased to present Startup

More information

Venture Capital Returns to Smaller Size Funds

Venture Capital Returns to Smaller Size Funds Dialing Down: Venture Capital Returns to Smaller Size Funds Venture Capital Update Written by: Sven Weber Managing Director 650.855.3049 sweber@svb.com Jason Liou Research Senior Associate 650.855.3043

More information

The ETF segment grows by 155 new products and attracts three new issuers: State Street Global Advisors, Ossiam and Raiffeisen.

The ETF segment grows by 155 new products and attracts three new issuers: State Street Global Advisors, Ossiam and Raiffeisen. Milestones SIX Swiss Exchange goes back more than 150 years. In 1996, fully electronic trading replaced the traditional floor trading system at the stock exchanges of Geneva (founded in 1850), Zurich (1873)

More information

Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends

Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends Reference Code: GDME0470MD Publication Date: March 2015 Independent Medical Equipment Research M&A Trends and Analysis

More information

Québec s Venture Capital Market in 2010

Québec s Venture Capital Market in 2010 Québec s Venture Capital Market in 2010 A REPORT PREPARED FOR RÉSEAU CAPITAL Quebec s Private Equity and Venture Capital Association FEBRUARY 2011 2011 by Thomson Reuters (Canada); All Rights Reserved

More information

Global Security pipeline Finance and Investment Trends in Homeland Security 2Q 2010

Global Security pipeline Finance and Investment Trends in Homeland Security 2Q 2010 Global Security pipeline Finance and Investment Trends in Homeland Security 2Q 2010 2Q08 3Q08 4Q08 1Q09 2Q09 3Q09 4Q09 $ billion Global Venture Capital & Private Equity Investment 2Q 2010 6.0 5.0 4.0 3.0

More information

MarketsandMarkets. Publisher Sample

MarketsandMarkets.  Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Life Science Competitiveness Indicators

Life Science Competitiveness Indicators Life Science Competitiveness Indicators March 215 Life Science Competitiveness Indicators 1 Preface This report brings together in one place a set of competitiveness indicators covering a range of aspects

More information

Global Content Delivery Networks

Global Content Delivery Networks MARKET FORECAST NOV 2015 Global Content Delivery Networks Market Overview 2015 Jim Davis, Senior Analyst, Service Providers After enjoying robust growth in 2014, the CDN market will see some effects from

More information

VCTs: Investing for the future

VCTs: Investing for the future The Association of Investment Companies VCTs: Investing for the future VCT investment 1996 to 2012 May 2013 www.theaic.co.uk About the AIC The Association of Investment Companies (AIC) represents closed-ended

More information

About Our Private Investment Benchmarks

About Our Private Investment Benchmarks 1. What is a benchmark? FREQUENTLY ASKED QUESTIONS A benchmark is a standard of measurement for investment performance. One of the more common types of benchmarks is an index which, in this case, measures

More information

Trade Sales of Biotechnology and Specialty Pharma Companies 2005-2008

Trade Sales of Biotechnology and Specialty Pharma Companies 2005-2008 HBM / M&A Survey Trade Sales of nology and Specialty Companies -8 Further information about the survey including a list of transactions can be found under www.hbmpartners.com/survey. The use of data and

More information

Key contacts. EMEA Investor Intentions Survey 2015. www.cbre.eu. CBRE Research

Key contacts. EMEA Investor Intentions Survey 2015. www.cbre.eu. CBRE Research Key contacts For more information about this regional special report, please contact: Michael Haddock Senior Director, EMEA Research t: +44 7 182 3274 e: michael.haddock@cbre.com For more information regarding

More information

Statistics Compendium EBAN 2014. 5.5b

Statistics Compendium EBAN 2014. 5.5b Statistics Compendium EBAN 2014 5.5b The Statistics Compendium is Europe s most extensive annual research on the activity of business angels and business angel networks. It provides information on the

More information

The German Venture Capital Market from a U.S. Perspective

The German Venture Capital Market from a U.S. Perspective The German Venture Capital Market from a U.S. Perspective I. Introduction Emerging growth companies in the United States have been benefiting from the sophisticated venture capital market of the United

More information

2015 Global venture capital confidence survey results How confident are investors? September 15, 2015

2015 Global venture capital confidence survey results How confident are investors? September 15, 2015 2015 Global venture capital confidence survey results How confident are investors? September 15, 2015 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing

More information

Nanotechnology in Medicine

Nanotechnology in Medicine E UROPEAN B IOTECHNOLOGY C ENTER Nanotechnology in Medicine New Perspectives for the Life Sciences Industry E Table of Contents Page Preface 4 I. Summary 5 II. Defining Medical Nanotechnology 6 1. What

More information

(CRISPR, TALEN, ZFN),

(CRISPR, TALEN, ZFN), Brochure More information from http://www.researchandmarkets.com/reports/3927515/ Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal

More information

Trends in Healthcare Investments and Exits 2016

Trends in Healthcare Investments and Exits 2016 Trends in Healthcare Investments and Exits 06 Investor Confidence and Innovation Drive Healthcare Venture to New Heights Written by Jonathan Norris Managing Director Silicon Valley Bank M 650.575.377 jnorris@svb.com

More information